A Phase III, Multicenter, Open Label, Randomized Study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to Evaluate Lot-To-Lot Consistency and to Investigate Potential Interference With Routine UIP Vaccinations in Healthy Infants in India.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 04 May 2017
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary) ; Hib-DTaP-hepatitis B vaccine; Poliovirus vaccine; Rotavirus vaccine
- Indications Rotavirus infections
- Focus Pharmacodynamics; Registrational
- Sponsors Serum Institute of India
- 08 Mar 2017 Planned End Date changed from 1 Aug 2016 to 1 Apr 2017.
- 08 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Apr 2016 Status changed from not yet recruiting to recruiting.